Integritas Communications

A Patient With Severe Asthma in Need of Additional Control

Overview / Abstract:	Severe asthma is thought to affect about 5% to 10% of the total population of patients with asthma. The detrimental consequences of uncontrolled severe asthma are significant, leading to serious exacerbations, deterioration of lung function, and pronounced impact on quality of life. The emergence of biologic therapies has revolutionized the treatment of severe asthma. Dr. Flavia Hoyte consults with Dr. Njira Lugogo to discuss a patient with poorly controlled, late-onset severe disease who may be a candidate for biologic therapy.
Expiration	Aug 18, 2024
Format	Online, Webinar / Webcast / Video
Credits / Hours	0.5
Accreditation	ACCME
Presenters / Authors / Faculty	Njira Lucia Lugogo, MD, MS Associate Professor of Internal Medicine Asthma Program Director Division of Pulmonary & Critical Care Medicine University of Michigan Pulmonary & Critical Care Medicine Ann Arbor, Michigan Flavia Hoyte, MD Associate Professor of Medicine, Division of Allergy and Immunology Director, Allergy and Clinical Immunology Fellowship Program National Jewish Health/University of Colorado Denver, Colorado
Sponsors / Supporters / Grant Providers	This activity is provided by Integritas Communications. This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.
Keywords / Search Terms	Integritas Communications severe asthma, asthma, patient care, shared-decision making, biologic-based treatment, pathophysiology Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map